BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31344280)

  • 1. Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.
    Kyritsi K; Chen L; O'Brien A; Francis H; Hein TW; Venter J; Wu N; Ceci L; Zhou T; Zawieja D; Gashev AA; Meng F; Invernizzi P; Fabris L; Wu C; Skill NJ; Saxena R; Liangpunsakul S; Alpini G; Glaser SS
    Hepatology; 2020 Mar; 71(3):990-1008. PubMed ID: 31344280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
    Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
    FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling.
    Meadows V; Kennedy L; Ekser B; Kyritsi K; Kundu D; Zhou T; Chen L; Pham L; Wu N; Demieville J; Hargrove L; Glaser S; Alpini G; Francis H
    Hepatology; 2021 Nov; 74(5):2684-2698. PubMed ID: 34164827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
    Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
    Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockout of the Tachykinin Receptor 1 in the Mdr2
    Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
    Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
    McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
    Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis.
    Chen L; Zhou T; White T; O'Brien A; Chakraborty S; Liangpunsakul S; Yang Z; Kennedy L; Saxena R; Wu C; Meng F; Huang Q; Francis H; Alpini G; Glaser S
    Hepatology; 2021 Jun; 73(6):2411-2428. PubMed ID: 32964473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.
    Wu N; Meng F; Invernizzi P; Bernuzzi F; Venter J; Standeford H; Onori P; Marzioni M; Alvaro D; Franchitto A; Gaudio E; Glaser S; Alpini G
    Hepatology; 2016 Sep; 64(3):865-79. PubMed ID: 27115285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
    Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
    Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2
    O'Brien A; Zhou T; White T; Medford A; Chen L; Kyritsi K; Wu N; Childs J; Stiles D; Ceci L; Chakraborty S; Ekser B; Baiocchi L; Carpino G; Gaudio E; Wu C; Kennedy L; Francis H; Alpini G; Glaser S
    Hepatol Commun; 2022 Jul; 6(7):1574-1588. PubMed ID: 35271760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
    Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
    Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2
    Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G
    Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic rats.
    McMillin M; DeMorrow S; Glaser S; Venter J; Kyritsi K; Zhou T; Grant S; Giang T; Greene JF; Wu N; Jefferson B; Meng F; Alpini G
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G410-G418. PubMed ID: 28751425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2
    Zhou T; Kyritsi K; Wu N; Francis H; Yang Z; Chen L; O'Brien A; Kennedy L; Ceci L; Meadows V; Kusumanchi P; Wu C; Baiocchi L; Skill NJ; Saxena R; Sybenga A; Xie L; Liangpunsakul S; Meng F; Alpini G; Glaser S
    EBioMedicine; 2019 Oct; 48():130-142. PubMed ID: 31522982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
    Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
    Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
    Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2
    Meadows V; Kennedy L; Hargrove L; Demieville J; Meng F; Virani S; Reinhart E; Kyritsi K; Invernizzi P; Yang Z; Wu N; Liangpunsakul S; Alpini G; Francis H
    Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165557. PubMed ID: 31521820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2
    Fuchs CD; Dixon ED; Hendrikx T; Mlitz V; Wahlström A; Ståhlman M; Scharnagl H; Stojakovic T; Binder CJ; Marschall HU; Trauner M
    Hepatol Commun; 2022 Sep; 6(9):2368-2378. PubMed ID: 35691019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.
    Li X; Liu R; Yang J; Sun L; Zhang L; Jiang Z; Puri P; Gurley EC; Lai G; Tang Y; Huang Z; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2017 Sep; 66(3):869-884. PubMed ID: 28271527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults.
    Omenetti A; Yang L; Gainetdinov RR; Guy CD; Choi SS; Chen W; Caron MG; Diehl AM
    Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G303-15. PubMed ID: 21071507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.